MOACM
ARNA

Mutual of America Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Mutual of America Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,146
Closed -$4.66M – 1648
2021
Q4 		$4.66M Sell
50,146
-383
-0.8% -$25.2K 0.05% 603
2021
Q3 		$3.01M Buy
50,529
+14,712
+41% +$869K 0.03% 780
2021
Q2 		$2.44M Buy
+35,817
New +$2.33M 0.02% 900

Mutual of America Capital Management's ARNA Position: Q1 2022 in Review

Mutual of America Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50,146 shares — an estimated $4.66M sold.

Mutual of America Capital Management first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $4.66M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Mutual of America Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 50,146 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.66M.
  • Mutual of America Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
  • Mutual of America Capital Management's Arena Pharmaceuticals Inc position peaked at $4.66M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Mutual of America Capital Management's 13F filing for Q1 2022, filed 2 May 2022.